Haematology JC048: Family History Of Anaemia: Inherited Causes Of Anaemia, Haemolytic Anaemia, Aplastic Anaemia Flashcards

1
Q

Haemolytic anaemia

A
  • Anaemias which result from ↑ Rate of destruction of circulating RBC
  • Compensatory ↑ Production from BM (if BM reserve is adequate)

Classification:
- Hereditary vs Acquired
- Intrinsic vs Extrinsic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hereditary / Inherited Haemolytic anaemia

A

ALL **Intrinsic
1. **
Membranopathy
- Hereditary spherocytosis

  1. ***Enzymopathy
    - G6PD deficiency
    - Pyruvate kinase deficiency
  2. ***Haemoglobinopathy
    - HbS (sickle cell anaemia), HbH, Unstable haemoglobinopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acquired Haemolytic anaemia

A

Mostly ***Extrinsic except Paroxysmal nocturnal haemoglobinuria

Intrinsic RBC defect:
1. Paroxysmal nocturnal haemoglobinuria (PNH)
- **PIGA gene mutation —> deficiency of glycophosphatidylinositol (important for anchoring cell surface protein **CD55, CD59) —> deficiency of CD55, CD59 —> complement mediated lysis of RBC (Intravascular haemolysis)

Extrinsic factors causing RBC damage:
1. Immune
- **Autoimmune (due to AutoAb)
- **
Alloimmune
—> Transfusion reactions
—> Haemolytic disease of newborn
- **Drug-induced (e.g. **Methyldopa, some antibiotics)

  1. Heat, venoms, chemicals damaging RBC membrane
  2. Drugs, chemicals oxidising Hb and other cellular components
  3. Red cell fragmentation syndromes
    - **MAHA (e.g. TTP)
    - **
    Mechanical haemolytic anaemia (e.g. Mechanical heart valves)
  4. Induced by microorganisms
    - Bacterial infection of RBC (e.g. Clostridium perfringens)
    - ***Parasitic infection of RBC (e.g. Malaria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

***History taking of Haemolytic anaemia

A
  1. Family history
  2. Ethnicity (e.g. **sickle cell anaemia in black, **thalassaemia in SE Asian)
  3. Infection (e.g. ***malaria)
  4. Drugs
  5. Transfusion history
  6. Co-existing illnesses e.g. ***Autoimmune diseases, Lymphoproliferative neoplasm
  7. History of ***gallstone (∵ longstanding haemolysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

***Clinical features of Haemolytic anaemia

A
  1. Pallor
  2. ***Jaundice (Acholuric jaundice ∵ haemolysis but NO tea colour urine ∵ unconjugated bilirubin (vs in obstructive jaundice))
  3. ***Haemoglobinuria in intravascular haemolysis (e.g. Paroxysmal nocturnal haemoglobinuria (PNH), massive haemolysis due to drug-induced haemolysis in G6PD deficiency)
  4. ***Splenomegaly
    - Acute hemolytic anemias cause splenomegaly with congestion (bloody spleen) (web)
    - Chronic: decreased sequestration of diseased erythrocytes —> less congestion but is instead attributed to diffuse proliferation of macrophages, phagocytosis, and concurrent hyperplasia of the white pulp due to ongoing antigenic stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

***Laboratory features of Haemolytic anaemia

A
  1. CBP
    - Anaemia (mildly **macrocytic usually)
    - **
    Reticulocytosis
  2. Biochemistry
    - **↑ Unconjugated bilirubin, ↑ LDH
    - **
    ↓ serum Haptoglobin (Hb bind to serum Haptoglobin —> use up Haptoglobin first)
    - ***↑ Methaemalbumin (Hb then bind to Albumin —> ↑ Methaemalbumin)
  3. Blood film
    - ***Polychromasia (∵ reticulocytosis)
    - Spherocytes (in Hereditary spherocytosis, Immune haemolytic anaemia)
    - RBC fragmentation (Schistocytes) (in MAHA)
    - RBC agglutination (in Cold agglutinin disease)
  4. Other investigation
    - ***Direct antiglobulin test (DAT) / Direct Coombs test —> positive in Immune haemolytic anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Autoimmune Haemolytic Anaemia (AIHA)

A
  • Autoimmune Ab against self RBC
  • Warm / Cold AutoAb (depending on temp which Ab binds better to RBC)

Warm type (37oC)
- **IgG
Causes:
1. Idiopathic
2. Secondary
- Drugs e.g. **
Methyldopa
- Autoimmune diseases e.g. **SLE
- Lymphoproliferative disorders e.g. **
CLL, Follicular lymphoma

Cold type (4oC)
- IgM
Causes:
1. Idiopathic (
Cold agglutinin disease —> **Acrocyanosis)
2. Secondary
- Infections e.g. **
Mycoplasma pneumonia, ***Infectious mononucleosis
- Lymphoproliferative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis of AIHA

A
  1. CBP
    - ↓ Hb
    - ***↑ Reticulocyte
  2. Blood film
    - ***Polychromasia
    - Microspherocytes
  3. Biochemistry
    - ↑ Unconjugated bilirubin, ↑ LDH
    - ↓ Haptoglobin
    - ↑ Methaemalbumin
  4. Specific tests
    - ***Direct antiglobulin test (DAT): test for presence of AutoAb coating RBC in patient
    —> add Antihuman Ab (Coombs agent, from animals)
    —> Antihuman Ab binds to AutoAb on RBC
    —> form links between RBC
    —> RBC agglutinate
    (DAT can also test for AlloAb)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of AIHA

A
  1. Transfusion if necessary
  2. **Folate supplement (for **all patients with ***any form of haemolytic anaemia, ∵ ↑ in demand for folate)
  3. Decrease further haemolysis
    - **Steroids / immunosuppressants in AIHA
    - Avoidance of certain drugs in drug-induced haemolytic anaemia
    - **
    Keep warm in cold agglutinin disease
    - ***Splenectomy
  4. Treat underlying cause if necessary
    - e.g. AIHA due to underlying Lymphoproliferative disorder, SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aplastic anaemia

A
  • Pancytopenia resulting from ***BM hypoplasia / aplasia / failure

Classification:
- Congenital
- Acquired (Idiopathic vs Secondary to some BM insult)

  • Isolated aplasia of Erythroid series: **Pure red cell aplasia (PRA)
    —> Congenital: **
    Diamond-Blackfan syndrome
    —> Acquired: ***Lymphoproliferative disease, Thymoma, Parvovirus B19

Etiology:
1. **Idiopathic (70-80%) (believed to be **Autoimmune)

  1. Congenital (rare)
    - Fanconi anaemia, Dyskeratosis congenita, Shwachman-Diamond syndrome
  2. Drugs (cause aplasia / suppression of BM)
    - **Gold, Alcohol, Diclofenac acid, **Indomethacin, Chloramphenicol, ***Anticonvulsants
  3. Infection
    - ***Non-A, B, C hepatitis (sero-negative hepatitis)
  4. Environmental exposure
    - Benzene, Pesticide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathogenesis of Idiopathic Aplastic anaemia

A

Can be considered an Autoimmune disease:
- Immune (***T-cell) mediated suppression of BM stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical features of Aplastic anaemia

A
  1. ***Pancytopenia symptoms
    - Anaemia
    - Neutropenia (infection risk)
    - Thrombocytopenia (bleeding tendency)
  2. ***NO lymphadenopathy
  3. ***NO hepatosplenomegaly
  4. In young patients, watch out for presence of **congenital physical abnormalities (indicate **Inherited BM failure syndromes)
    - e.g. Fanconi anaemia, Dyskeratosis congenita, Shwachman-Diamond syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Investigations of Aplastic anaemia

A
  1. CBP
    - Pancytopenia
    - Macrocytic anaemia
    - ***Low reticulocyte count
  2. Blood film
    - No Polychromasia
    - No Abnormal cells
  3. ***Autoimmune markers
    - see if autoimmune process e.g. SLE
  4. ***B12, Folate level
    - see if B12, Folate deficiency
  5. **BM trephine biopsy
    - required for assessment of **
    cellularity
    - aspiration cytology not good enough
  6. Specialised test
    - Flow cytometry for CD55, CD59 deficient RBC (to rule out PNH ∵ PNH also associated with Aplastic anaemia)
    - Chromosome breakage with diepoxybutane (to screen for ***Fanconi anaemia (Inherited BM failure syndromes))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Definition of Severity of Aplastic anaemia

A
  1. Severe aplastic anaemia
    - BM cellularity ***<25%
    2 of 3 of following cytopenia:
    - Neutrophil <0.5
    - Platelet <20
    - Reticulocyte <20
  2. Very severe aplastic anaemia
    - same as above but Neutrophil <0.2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of Aplastic anaemia

A

Mild / Moderate:
- NO treatment
- Support with ***blood products

Severe:
1. 1st line: **Allogeneic HSCT (for **young patients with matched sibling donors)
2. Anti-thymocyte/lymphocyte globulin (
ATG) + **Cyclosporine
3. Cyclosporine A only
4. Support with blood products, Fe chelation
5. **
Eltrombopag (thrombopoietin receptor agonist, high dose) + **ATG + **Cyclosporine —> very high response rate —> now standard for those cannot undergo AlloHSCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

***Inherited BM failure syndromes

A

Pancytopenia:
1. Fanconi anaemia
2. Dyskeratosis congenita
3. Shwachman-Diamond syndrome

Anaemia (Isolated aplasia of Erythroid series: ***Pure red cell aplasia (PRA)):
1. Diamond-Blackfan anaemia
2. Congenital dyserythropoietic anaemia

17
Q

Fanconi anaemia, Dyskeratosis congenita, Shwachman-Diamond syndrome, Diamond-Blackfan syndrome, Congenital dyserythropoietic anaemia

A

X rmb

  1. Fanconi anaemia
    - Inheritance: AR, XLR
    - **Somatic abnormalities: Yes (missing thumb, hyper / hypopigmentation of skin)
    - **
    BM failure: Aplastic anaemia
    - Short telomeres: Yes
    - ***Malignancy (perhaps ∵ chromosomal instability): Yes
    - Chromosome instability: Yes
    - Genes involved: 13
  2. Dyskeratosis congenita
    - Inheritance: XLR, AR, AD
    - Somatic abnormalities: Yes (reticulosis in skin, nail dystrophy, leukoplakia)
    - BM failure: Aplastic anaemia
    - Short telomeres: Yes
    - Malignancy: Yes
    - Chromosome instability: Yes
    - Genes involved: 6
  3. Shwachman-Diamond syndrome
    - Inheritance: AR
    - Somatic abnormalities: Yes
    - BM failure: Aplastic anaemia
    - Short telomeres: Yes
    - Malignancy: Yes
    - Chromosome instability: Yes
    - Genes involved: 1
  4. Diamond-Blackfan syndrome
    - Inheritance: AD
    - Somatic abnormalities: Yes
    - BM failure: Pure red cell aplasia
    - Short telomeres: ?
    - Malignancy: Yes
    - Chromosome instability: ?
    - Genes involved: 7
  5. Congenital dyserythropoietic anaemia
    - Inheritance: AR, AD
    - Somatic abnormalities: Rare
    - BM failure: Ineffective erythropoiesis
    - Short telomeres: ?
    - Malignancy: No?
    - Chromosome instability: ?
    - Genes involved: 1
18
Q

Inherited causes of anaemia: Pathophysiology

A
  1. Inherited BM failure syndromes: Pancytopenia, Pure red cell aplasia (PRA)
  2. Membranopathy —> Haemolytic anaemia
  3. Haemoglobinopathy (Thalassaemia) —> Haemolytic anaemia
  4. RBC metabolism disorders (Enzymopathy) —> Haemolytic anaemia
19
Q

History taking in Inherited causes of Anaemia

A
  1. Family history
    - ***pattern of inheritance
  2. ***Age of onset
    - tend to present at early age
  3. Drug history
    - G6PD deficiency: only develop haemolysis when challenged by ***oxidising drugs
  4. Symptoms of haemolysis
    - ***Jaundice
  5. ***Transfusion requirement
    - long term transfusion in Hereditary spherocytosis
  6. Complications
    - including those due to long-term red cell transfusion e.g. ***Fe overload
20
Q

***Clinical features in Inherited causes of Anaemia

A
  1. Pallor
  2. Jaundice
  3. Splenomegaly
  4. ***Skin complexion
  5. ***Skeletal deformities
21
Q

Disorders of RBC membrane (Membranopathy)

A

Types:
1. Hereditary spherocytosis (loss of central pallor)
2. Hereditary elliptocytosis + Hereditary pyropoikilocytosis
3. Southeast Asian ovalocytosis
4. Hereditary acanthocytosis (not necessarily inherited, could be associated with liver disease)
5. Hereditary stomatocytosis

Pathophysiology:
- Mutation in genes encoding ***cytoskeleton protein (responsible for vertical / horizontal interaction)

X rmb
1. α-spectrin
- cytoskeleton network
- Hereditary spherocytosis (HS), Hereditary elliptocytosis (HE)

  1. β-spectrin
    - cytoskeleton network
    - Hereditary pyropoikilocytosis, HS, HE
  2. Ankyrin
    - vertical contact
    - HS
  3. Band 3
    - anion exchange channel
    - HS, SEA ovalocytosis, Hereditary acanthocytosis
  4. Protein 4.1
    - spectrin-actin contact
    - HE
  5. Protein 4.2
    - spectrin-ankyrin interaction
    - HS (Japan)
22
Q

Hereditary spherocytosis

A
  • Spherocytes on blood film (only 20% of all RBC (SpC Paed))
  • Haemolytic anaemia: mild (well compensated) - severe
  • ***Extravascular haemolysis —> No Haemoglobinuria
  • AD
  • 60% result from defect in ***Ankyrin-Spectrin complex / Vertical interaction

Clinical feature:
1. **Jaundice (Unconjugated hyperbilirubinaemia)
2. **
Splenomegaly
3. **Gallstone
4. **
Aplastic crisis (Primary ***parvovirus B19 infection during chronic haemolysis)

CBP:
1. Spherocytes on blood film
2. Extravascular haemolysis
3. ***MCHC often ↑ (∵ cellular dehydration)

Investigations:
1. Osmotic fragility test (past) (∵ spherocytes more susceptible to osmotic lysis)
2. Flow cytometry: ***Eosin-5-maleimide binding (↓ binding of RBC to the dye in HS)

23
Q

Treatment of Hereditary spherocytosis

A
  1. ***Folate supplement (as in all haemolytic anaemia)
  2. Compensated haemolysis: No specific treatment (no / mild anaemia)
  3. ***Cholecystectomy (if symptomatic gallstones)
  4. Splenectomy (if severe haemolysis)
24
Q

Disorders of Haemoglobin

A
  1. Thalassaemia
    - Hb disorders with ***↓ in rate of synthesis of >=1 globin chains
  2. Haemoglobinopathies
    - Hb disorders with a ***structurally abnormal Hb e.g. HbS
    - in some cases, there are concomitant ↓ synthesis of globin chains (i.e. “Thalassaemic haemoglobinopathies” e.g. Hb Constant Spring, HbE)
25
Disorders of RBC metabolism (Enzymopathy)
aka ***Congenital non-spherocytic haemolytic anaemia (∵ no spherocytes vs Hereditary spherocytosis / Immune-mediated haemolysis) 1. ***G6PD deficiency 2. ***Pyruvate kinase deficiency 3. Deficiency of other glycolytic pathway enzymes (rare) G6PD deficiency: - important in generation of reducing power: GSH —> needed to withstand oxidative stress (esp. RBC always in contact with O2) Glycolytic enzyme deficiency: - RBC nucleus expelled in BM before in circulation —> no protein synthesis —> rely on existing enzymes to generate energy to maintain protein integrity / osmolality —> deficiency in enzymes —> no ATP generated —> RBC susceptible to haemolysis
26
G6PD deficiency
- ***X-linked recessive - Incidence in HK: 4.5% in males, 0.5% in females - >100 variants associated with enzyme deficiency - Type B refers to Wild-type Classified based on severity (residual enzyme activity): Class 1: Severe ***<2%, Santiago de Cuba (Gly447Arg) —> Haemolytic anaemia (***unprovoked chronic haemolysis), acute exacerbation Class 2: ***<10%, Canton (Arg45Leu), Mediterranean (Ser188Phe) —> Favism, Acute IV haemolysis (drug induced), Neonatal Jaundice Class 3: Moderate ***<60%, A- (Val68Met, Asn126Asp) —> No clinical effect Class 4: ***100%, Type B (wild type), Type A (Asn126Asp) —> No clinical effect Clinical features: 1. Intravascular Haemolysis with Haemoglobinuria (acute / chronic) (not common) 2. Precipitated by infection, acute medical illness, drugs, fava beans (most of the time) - drugs: Sulphonamides, Rasburicase, Primaquine Investigation: 1. Blood film - Polychromasia - ***Ghost / Hemi-ghost cells (∵ oxidative changes) —> ghost: no Hb in cell (can only see membrane) (得返個殼) Diagnosis: 1. ***G6PD assay for enzyme level - may be ***normal during acute phase (i.e. acute haemolysis) as young RBC and reticulocytes may have normal G6PD levels Treatment: 1. Supportive 2. ***Blood transfusion 3. ***Folate supplement 4. Stop + Avoid offending agents
27
Revision: Haemolytic anaemia
Destruction of RBC accelerated —> shortened RBC life span - may not have anaemia in presence of adequate marrow compensation —> compensated haemolysis Extravascular haemolysis: Spleen: Macrophage clearing up damaged/defective RBC, Warm AIHA Intravascular haemolysis: G6PD deficiency, Microangiopathic haemolytic anaemia, Cold AIHA Causes: - Intrinsic / Extrinsic (See previous note) - Acquired / Inherited Acquired 1. Immune-mediated - Ab to RBC surface antigens —> Spherocytes + ***positive DAT 2. Microangiopathic - mechanical disruption of RBC in circulation —> Red cell fragmentation syndromes —> Schistocytes 3. Infection - Malaria, Clostridium —> cultures, serologies Hereditary 1. Enzymopathies - G6PD deficiency —> Low G6PD activity 2. Membranopathies - Hereditary spherocytosis —> Spherocytes, family history, ***negative DAT (vs Warm AIHA) 3. Hemoglobinopathies - Thalassaemia, Sickle cell disease —> Hemoglobin electrophoresis, genetic studies Laboratory findings: 1. Increased Haemoglobin breakdown (↑ Total + Unconjugated Bilirubin) 2. Red cell damage - ***Spherocytes (Hereditary spherocytosis / Warm AIHA) - ***Schistocytes (Microangiopathic haemolytic anaemia) - Sickle cell (Sickle cell anaemia) 3. Reticulocytosis (Polychromasia) 4. Circulating nucleated RBC 5. Erythroid hyperplasia (in BM) 6. Intravascular haemolysis RBC damaged in circulation —> release free Hb (↑ plasma Hb) —> Free Hb bind to Haptoglobin first (↓ Haptoglobin) —> Haptoglobin used up —> Hb bind to Albumin (↑ Methaemalbumin, +ve Schumm’s test) —> Excess Hb: 1. Haemoglobinaemia 2. Filter in glomerulus (Haemoglobinuria —> Dark urine) 3. Iron deposition in renal tubules (Haemosiderin) —> re-excreted in urine inside dislodged cells (Haemosiderinuria: Sign of chronic intravascular haemolysis)
28
Revision: Autoimmune haemolytic anaemia
RBC destruction mediated by Ab directed against RBC antigens - Spherocytosis (warm AIHA) - RBC agglutination (cold AIHA) 1. Autoimmune (AutoAb) - warm / cold - many idiopathic - associated with autoimmune disease (e.g. SLE), lymphoproliferative disorder, mycoplasma pneumonia, infectious mononucleosis - +ve DAT 2. Alloimmune (AlloAb) - Haemolytic transfusion disorder (ABO incompatible blood transfusion) - Haemolytic disease of newborn (Anti-D in Rh D -ve mother —> haemolysis in Rh D +ve infant) 3. Drug-induced - Hapten mechanism: Ab directed against drug-cell membrane complex - Immune complex mechanism: drug-Ab complex on RBC surface —> Complement deposition - Autoimmune
29
Revision: Thalassemia
Hyperproliferative anaemia Genetic disorder of globin chain synthesis - ↓ synthesis of particular globin chains —> imbalance in available globin chains —> excess chains polymerise but ***unstable —> precipitate —> ***Early destruction of RBC precursors in BM (ineffective erythropoiesis) / ***Shorten RBC life span Laboratory findings: - ***Hypochromic Microcytic RBC (defective haemoglobinisation) - Abnormal globin tetramers (Hb H / Hb Barts) / Normal haemoglobin present in non-physiological amount (e.g. Hb F) —> Increased O2 affinity —> Tissue hypoxia (cannot unload O2) ***Laboratory diagnosis of Thalassaemia: 1. CBC, RBC indices 2. Peripheral blood film - ***Hypochromic, Microcytic - ***Reticulocytosis - Anisocytosis (嚴重先有) - Poikilocytosis (嚴重先有) - Normoblasts - ***Target cells 3. β-Thalassaemia —> ***Hb F, Hb A2 quantitation by chromatography / electrophoresis 4. α-Thalassaemia —> Detection of ***Hb H inclusions 5. Genotyping for complex cases / Prenatal diagnosis Prevention of Hb Bart’s hydrops fetalis and β-Thalassemia Major 1. Public health education 2. Counselling of specific target groups (couples before / soon after marriage) 3. Carrier detection 4. Antenatal, Prenatal diagnosis
30
Revision: α-Thalassaemia
- defective fetal + adult Hb production - Fetus: excess γ chains (Hb Bart’s: γ4) - Adult: excess β chains (Hb H: β4) —> may be masked during smear examination by concomitant β-Thalassemia —> ∵ cannot produce β-chains 1. α-Thalassaemia trait (1 / 2 gene deletion) - 1 gene deletion: clinically / haematological silent - 2 gene deletion: normal / slightly ↓ haemoglobin, ***↑ RBC count, ***Hypochromic Microcytic RBC - ***HbH inclusions: precipitated out to form blue-green granules when RBC incubated with Brilliant cresyl blue stain (哥爾夫球) 2. Hb H disease (3 gene deletion) - ***Chronic anaemia - ***Splenomegaly (to remove RBC) - ***~ALL patient have normal physical development (small proportion has thalassaemic facies) - can be Asymptomatic - generally NOT transfusion dependent - excess β chains —> Hb H (5-40% total Hb) - small amount of Hb Bart may be present - variable features - exacerbated by pregnancy / infection - Complication: Hypersplenism —> Splenectomy indicated 3. Hb Bart’s hydrops fetalis (4 gene deletion) - no α-chain found - incompatible with life (unless start vigorous treatment early in fetal life) - excess γ chains —> Hb Bart’s (γ4) - edematous fetus due to ***heart failure (a result of anaemia) and ***liver dysfunction —> condition diagnosed with ultrasonography, confirmed with prenatal genetic diagnosis Molecular genetics - 90% due to ***deletions of DNA (vast majority removal of both α-genes from α-gene cluster, single α-gene deletions less common) - 10% due to ***non-deletional type (***Hb Constant Spring, Hb Quong Sze) —> more severe S/S, complications
31
Revision: β-Thalassaemia
Reduced (β+) / Absent (βo) synthesis of β-globin chain - β chain production only becomes predominant in post-natal period —> severe β-Thalassemia (β-Thalassemia major) manifest only when patient ***>= 3 months old (***大個d先見到Symptoms) 1. β-Thalassemia Trait / Minor - ***Heterozygous for βo / β+ - Asymptomatic - slightly ↓ Hb level - ***↓ MCV (Microcytic), ↓ MCH (Hypochromic) - ***↑ RBC count - ***↑ Hb A2 (MOST important diagnostic feature for heterozygous β-Thalassemia) - many have minor ↑ Hb F 2. β-Thalassemia Major (Cooley’s anaemia) - total absence / marked reduction of β-globin chains —> excessive α-globin chains precipitate out in RBC precursor cells —> extensive intramedullary destruction of RBC precursors (***Ineffective erythropoiesis) —> ***marked expansion of BM —> ***Hyperproliferative anaemia - ***↑ destruction of peripheral RBC (***Haemolytic element) - ***↑ Hb F level —> ***selective survival advantage (explain high level of Hb F) Blood film: - Marked RBC ***Anisocytosis (***↑ RDW) + ***Poikilocytosis - ***Hypochromic - ***Numerous nucleated RBC (Normoblast) Homozygous βo: - complete absence of Hb A - small amount of Hb A2 - ***HbF remainder (98%) Clinical features: 1. ***Thalassaemic facies 2. Protuberant abdomen (***Hepatosplenomegaly) 3. ***Poor musculoskeletal development 4. Complications e.g. Recurrent infections, spontaneous fractures, hypersplenism, leg ulcers, extramedullary haemopoiesis Treatment: - ***Blood transfusion - ***Iron overload —> Treat with ***Iron chelation therapy (Deferoxamine) ***3 Major genetic modifiers of disease severity (can be modified to milder clinical severity e.g. Thalassemia Intermedia): —> Nature of β-globin gene defect (whether mutation associated with severe phenotype) —> Configuration of α-globin gene locus (affect degree of α/β globin gene imbalance) —> Genetic determinants of Hb F level 3. Thalassemia Intermedia (Non-transfusion dependent Thalassemia (NTDT)) - symptomatic but milder than β-Thalassemia Major —> β-Thalassemia Intermedia —> Hb H disease —> Hb E β Thalassemia Hb E: - Haemoglobinopathy - point mutation of β gene at position 26 —> a.a. change from Glutamate to Lysine —> Abnormal Hb (Hb E) - mRNA of Hb E —> unstable —> ***underproduced abnormal Hb —> thalassaemic presentation - Heterozygous HbE —> Mild Microcytosis, No/Minimal anaemia (some have totally normal CBP) - Homozygous HbE —> Microcytosis, Mild anaemia - Compound heterozygous HbE + β-Thalassaemia —> Thalassaemia Intermedia syndrome, ***Splenomegaly, other complications Molecular genetics of β-Thalassaemia - Point mutations (NOT gene deletions) - Own unique set of mutations among different races